MoonLake Immunotherapeutics (MLTX) Sector
Health Care

(Current) $10.00
0.50 (5.26%) Open Price: 9.38

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients

(10/09/25) $9.38
(10/11/25) $9.50
(10/11/25) (Qty.)9,608,863
(10/09/25) $9.30
(10/09/25) $10.04
(09/28/25) $5.95
(09/21/25) $62.75
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing